- Sales stable – solid organic growth of 4.2% almost fully offsets negative foreign exchange effects of –4.7%
- Accelerated implementation of efficiency measures within the scope of the “Fit for 2018” transformation and growth program
- EBITDA pre one-time items increased by 10% to around € 3.25 billion – Key drivers are the positive business performance of all four divisions and the successful implementation of restructuring measures
- Earnings per share pre one-time items up 15% to € 8.78
- Business free cash flow again reaches the high previous year’s level of around € 3.0 billion
- Net financial debt lowered considerably to € 0.3 billion as of December 31, 2013
- Merck’s long-term credit ratings upgraded to “A“ (Standard & Poor’s) and “A3” (Moody’s)
| XLS |
|
Merck Group | Key figures |
|
||
|
|
|
|
|
|
|
|
|
|
|
€ million |
2013 |
2012 |
Change in % |
|
Total revenues |
11,095.1 |
11,172.9 |
–0.7 |
|
Sales |
10,700.1 |
10,740.8 |
–0.4 |
|
Operating result (EBIT) |
1,610.8 |
963.6 |
67.2 |
|
Margin (% of sales) |
15.1 |
9.0 |
|
|
EBITDA |
3,069.2 |
2,360.2 |
30.0 |
|
Margin (% of sales) |
28.7 |
22.0 |
|
|
EBITDA pre one-time items |
3,253.3 |
2,964.9 |
9.7 |
|
Margin (% of sales) |
30.4 |
27.6 |
|
|
Earnings per share pre one-time items (€) |
8.78 |
7.61 |
15.4 |
|
Business free cash flow |
2,960.0 |
2,969.3 |
–0.3 |
search hit 28
